Jaishankar welcomes USTR Katherine Tai's positive stance on IPR issues

External Affairs Minister S Jaishankar appreciated Tai's stance on issues related to intellectual property rights of Covid-19 vaccines and support for efficient and robust supply chains

S Jaishankar
S Jaishankar
Press Trust of India Washington
2 min read Last Updated : May 28 2021 | 7:02 AM IST

External Affairs Minister S Jaishankar on Thursday welcomed the positive stance of US Trade Representative Katherine Tai on issues related to intellectual property rights of COVID-19 vaccines and her support for efficient and robust supply chains.

Jaishankar, 66, on Thursday had a meeting with Tai to discuss a wide range of bilateral trade issues. The minister described it as good discussions. "Welcomed her positive stance on IPR issues & support for efficient and robust supply chains," he said in a tweet after the meeting.

Early this month, Tai, after consultations with various stakeholders, had announced support to the move of India and South Africa to waive certain IP aspects of COVID-19 vaccines at the World Trade Organization (WTO). This step is likely to help in a big way in the fight against the pandemic.

"Our trade, technology and business cooperation are at the core of our strategic partnership. Enhancing them is vital to post-Covid economic recovery," Jaishankar said in a tweet.

According to the latest quarterly official data, India is the top ninth trade partner of the United States in goods and services. The total bilateral trade between India and the US from January to March this year was USD 24.8 billion. The list is topped by America's two neighbours: Mexico (USD 153.9 billion) and Canada (USD 151.1 billion), followed by China (USD 148.2 billion), Japan (USD 49.4 billion) and Germany (USD 46.7 billion).

According to the Department of Commerce, US exports of goods and services to India supported an estimated 1,98,000 jobs in 2015 (according to latest available data) -- 82,000 supported by goods exports and 1,16,000 supported by services exports.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusS JaishankarUS tradeCoronavirus VaccineIPR

First Published: May 28 2021 | 6:58 AM IST

Next Story